$QSI is an undervalued play.

Nuff said, proteus set to release in 2026, historical price point is at ~low $1 which is typically the lowest it remains with a few exception before it usually always go up to $2 or $3 on hype, dilution prospects remains low with cash on hand of above $200million set to last until 2028. Revenue is low which is expected as customer base is waiting for Proteus with capabilities to read up to over 20 proteome including PTM coverage (huge point in the proteomic industry) considering they target single molecules which gives them an insane niche over typical mass specs move that ILMN/TMO uses. There may even be a large premium buyout but who knows and there’s also the mysterious 30m investor which we all know is likely Nvidia but naysayers is saying its not but old posts of $RXRX comparison to $QSI with Nvidia style of investment says otherwise and given that QSI had a partnership with Nvidia to develop their product makes this highly likely. Good luck to all! Invest if you want or not but this is a penny stock and revenue is still low, but customer adoption funnel rates have significantly increased and their previous earning transcript even said they have collaboration with DoD (Government) labs. Hence, I rate this a pretty undervalued penny stock in my own personal opinion, nfa and dyor.